United States · Series B startup

Who invested in Totus Medicines

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Funding summaryUpdated 26 Oct 2026

$66Mraised across 1 round since 2023, from 1 source

Latest round
Series B, $66MDec 2023
Investors
2
See who backed them

The rounds

  1. Dec 2023
    Series B$66M

    Source recorded

Founders and team

From Totus Medicines's own website: 3 on the team.

  • Navitor PharmaceuticalsCEO and Chairperson
  • Totus MedicinesCEO and Chairperson
  • Daisy ChhokarChief People Officer

Everyone who backed them

DCVCVC firm1round
Northpond VenturesPrivate equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Totus Medicines

Who invested in Totus Medicines?

Totus Medicines's investors include DCVC and Northpond Ventures.

How much has Totus Medicines raised?

Totus Medicines has raised $66M across 1 round since 2023.

When did Totus Medicines last raise?

Totus Medicines's most recent round was a Series B of $66M in Dec 2023.

What was Totus Medicines's biggest round?

Its most recent round, $66M in Dec 2023, is also its largest on record.

Who backed Totus Medicines first?

Totus Medicines's first round on record, in Dec 2023, was backed by DCVC and Northpond Ventures.

What stage is Totus Medicines at?

Totus Medicines's latest named round is a Series B, in Dec 2023.

Where is Totus Medicines based?

Totus Medicines is based in the United States.

Companies like Totus Medicines

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.